* Imunon Inc IMNN.OQ IMNN.O is expected to show a fall
in
quarterly revenue when it reports results on November 14.
* The Lawrenceville New Jersey-based company is expected to
report a 13.3% decrease in revenue to $108.33 thousand from
$125 thousand a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Imunon Inc is for a
loss
of 81 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Imunon Inc
is
$18, above its last closing price of $1.53.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -1.44 -1.12 -0.87 Beat 22.5
Mar. 31 2022 -0.99 -0.99 -1.82 Missed -83.8
Dec. 31 2021 -0.90 -0.90 -3.62 Missed -302.2
Sep. 30 2021 -1.27 -1.20 -0.90 Beat 25
Jun. -1.20 -1.20 -0.90 Beat 25
30 2021
-1.35
Dec. 31 2020 -1.95 -1.95 -0.75 Beat 61.5
Sep. 30 2020 -1.20 -1.90 -3.60 Missed -89.5
This summary was machine generated November 11 at 14:50 GMT.
All figures in US dollars unless otherwise stated